Home/Filings/4/0001022079-25-000195
4//SEC Filing

KUPPUSAMY KARTHIK 4

Accession 0001022079-25-000195

CIK 0001022079other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 4:37 PM ET

Size

16.8 KB

Accession

0001022079-25-000195

Insider Transaction Report

Form 4
Period: 2025-07-30
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
Transactions
  • Exercise/Conversion

    Common Stock

    2025-07-30$86.63/sh+3,045$263,78813,705 total
  • Sale

    Common Stock

    2025-07-30$167.40/sh5,224$874,49810,660 total
  • Sale

    Common Stock

    2025-07-30$167.40/sh3,045$509,73310,660 total
  • Sale

    Common Stock

    2025-07-31$170.00/sh2,210$375,7008,450 total
  • Exercise/Conversion

    Non-Qualifed Stock Option (right to buy)

    2025-07-30$86.63/sh3,045$263,7880 total
    Exercise: $86.63Exp: 2029-02-18Common Stock (3,045 underlying)
  • Exercise/Conversion

    Non-Qualifed Stock Option (right to buy)

    2025-07-30$112.17/sh5,224$585,9760 total
    Exercise: $112.17Exp: 2030-02-18Common Stock (5,224 underlying)
  • Exercise/Conversion

    Common Stock

    2025-07-30$112.17/sh+5,224$585,97615,884 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,629
  • Common Stock

    (indirect: By Trust)
    358
Footnotes (4)
  • [F1]This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
  • [F2]These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
  • [F3]The options vested in three annual installments beginning with the first on February 18, 2020, the second on February 18, 2021 and the final on February 18, 2022.
  • [F4]The options vested in three annual installments beginning with the first on February 18, 2021, the second on February 18, 2022 and the final on February 18, 2023.

Issuer

QUEST DIAGNOSTICS INC

CIK 0001022079

Entity typeother

Related Parties

1
  • filerCIK 0001955217

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:37 PM ET
Size
16.8 KB